RxSight expects preliminary Q2 revenue down 4%
Overview
RxSight's preliminary Q2 2025 revenue expected to be down 4% yr/yr, missing analyst expectations, per LSEG data
Company revises 2025 revenue guidance downward, gross margin guidance upward
Sale of Light Delivery Devices decreased 45% compared to Q1 2025
Outlook
RxSight revises 2025 revenue guidance to $120 mln-$130 mln, down from $160 mln-$175 mln.
Company increases 2025 gross margin guidance to 72%-74%, up from 71%-73%.
RxSight sees 2025 operating expense guidance between $145 mln-$155 mln.
Result Drivers
REVENUE DECLINE - Q2 2025 revenue expected to fall 4% year-over-year and 11% from Q1 2025, missing analyst expectations, on decreased sales of Light Delivery Devices
LDD SALES DROP - Sales of Light Delivery Devices decreased 45% compared to Q1 2025 and 49% compared to Q2 2024
LAL SALES GROWTH - Despite overall revenue decline, Light Adjustable Lenses sales increased 13% compared to Q2 2024
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Miss | $33.60 mln | $39.80 mln (10 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 3 "hold" and 2 "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"
Wall Street's median 12-month price target for Rxsight Inc is $21.00, about 40.8% above its July 7 closing price of $12.43
Press Release: ID:nGNX2LHj70
Related Articles
Japan: Yen Likely to Rise or Stabilise, Unlikely to Fall, with High Odds for Bulls
TradingKey - We anticipate a high likelihood of the Japanese yen appreciating in the short term (0-3 months). This outlook is driven by two key factors: First, the diverging monetary policies of the U.S. and Japan (Federal Reserve rate cuts paired with Bank of Japan rate hikes) will support the...
BEST ETFs to BUY in July 2025
TradingKey - After a sharp V-shaped recovery in April and choppy gains through May, U.S. stocks accelerated their rally in June despite escalating Middle East tensions. The S&P 500 and Nasdaq Composite hit fresh year-to-date highs, underscoring the market’s resilience.
Goldman Sachs: Circle Is An Unique Crypto Asset with Strong Growth, But Valuation Concerns Warrant Neutral Rating
We initiate coverage of stablecoin issuer Circle Internet Group (CRCL) with a Neutral rating and an $83 12-month price target, based on 60.0x Q5-Q8 adjusted earnings, implying 54% downside. CRCL is a unique asset in the public markets, as the only pure play crypto-native company that has potential u
Prediction! Federal Reserve Chairman Jerome Powell's Next Move Will Be an Interest Rate Cut
The Federal Reserve must balance the risks of higher inflation with the risks of higher unemployment when making decisions on interest rates.Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »*Stock prices used were..
South Korea's Yoon, Poland's Duda condemn N.Korea troop dispatch to Russia
South Korean President Yoon Suk Yeol and Polish President Andrzej Duda on Thursday condemned North Korea's dispatch of troops to Russia for its war against Ukraine as a global security threat, Yoon's office said.
